Abstract |
A prospective noncontrolled study of the safety and potential efficacy of transurethral balloon catheter dilation of the prostate ( TUDP) in the treatment of benign prostatic hyperplasia (BPH) was performed in 73 subjects with moderate to severe symptoms and signs of prostatism who were selected on the basis of a quantitative symptom score (SS), uroflowmetry measurements, and residual urine volume. Seven patients had urinary retention. Mean age was 69.6 years (range, 59-95 years). TUDP was successfully accomplished in 70 patients (96%). There were no significant complications. Mean follow-up was 16.2 months (range, 6-36 months). Forty-six patients (66%) showed improved SS at the most recent follow-up. In 24 patients (34%) SS was unimproved, necessitating prostatectomy in 17 subjects (24%). Reduction in mean residual urine volume was not statistically significant. Only 38% of patients with median lobe enlargement showed improvement in SS, compared with 74% for the others. The authors conclude that TUDP is safe and shows promising effectiveness and that the ultimate demonstration of effectiveness requires a controlled clinical trial.
|
Authors | N F Wasserman, P K Reddy, G Zhang, P A Berg |
Journal | Radiology
(Radiology)
Vol. 177
Issue 2
Pg. 485-94
(Nov 1990)
ISSN: 0033-8419 [Print] United States |
PMID | 1699247
(Publication Type: Journal Article)
|
Topics |
- Aged
- Aged, 80 and over
- Catheterization
(methods)
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Prospective Studies
- Prostatic Hyperplasia
(physiopathology, therapy)
- Radiography
- Urethra
(diagnostic imaging, physiopathology)
- Urinary Bladder
(diagnostic imaging, physiopathology)
- Urination Disorders
(etiology)
|